PortViewPortView
Oramed Pharmaceuticals logo

Oramed Pharmaceuticals (ORMP) Stock Analysis

NASDAQHealthcareBiotechnology

$4.98+2.68%
1-year price historyRange $2.19 – $5.34
52-week range$4.98
$2.09$5.47

What Oramed Pharmaceuticals does

Oramed Pharmaceuticals Inc., founded in 2002 and based in New York, New York, specializes in the development of groundbreaking pharmaceutical treatments. Their primary focus is on creating orally ingested capsules or pills for the delivery of polypeptides, particularly aimed at managing diabetes. The company's leading product, ORMD-0801, is an oral insulin capsule that has successfully completed Phase II clinical trials for patients with diabetes. Oramed is also advancing ORMD-0901, an oral glucagon-like peptide-1 (GLP-1) capsule, which has concluded Phase I clinical trials for the treatment of type 2 diabetes. Additionally, an oral leptin capsule for weight loss is currently under development. The firm was originally incorporated as Integrated Security Technologies, Inc., before officially changing its name to Oramed Pharmaceuticals Inc. in April 2006.

Key metrics

Market cap
$203.81M
P/E (TTM)
2.58
EPS (TTM)
$1.93
Beta
1.16
Dividend yield
5.02%
Revenue / share
$0.00
50-day avg
$4.43
200-day avg
$3.70
52-week high
$5.47
52-week low
$2.09
CEO
Nadav Kidron

ETFs linked to ORMP

Broad-market and Healthcare sector ETFs an investor holding Oramed Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ORMP fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ORMP in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Oramed Pharmaceuticals?
Oramed Pharmaceuticals trades under the ticker ORMP on NASDAQ.
Which exchange is ORMP listed on?
ORMP is listed on NASDAQ.
What sector does Oramed Pharmaceuticals operate in?
Oramed Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ORMP in a portfolio?
PortView shows ORMP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.